CSC target genes (CD24, EpCAM, BMI1, and LGR5) were also downregulated after JNKi treatment (Figure 1D and Supplementary Figure S2A), suggesting that the JNK pathway might play a role in the regulation of CSCs in pancreatic cancer. Here, LGR5 is linked to familial pancreatic carcinoma.